Linezolid (Zyvox)

Jessica Hillard MD
{"title":"Linezolid (Zyvox)","authors":"Jessica Hillard MD","doi":"10.1016/S1068-607X(02)00114-2","DOIUrl":null,"url":null,"abstract":"<div><p><span><span>Linezolid (Zyvox) is a member of the first new category of antibiotics in 35 years. It is an </span>oxazolidinone that blocks bacterial protein synthesis by a method unlike any other antibiotic, making cross-resistance unlikely. It is available in oral and intravenous formulations and can be used to treat infections caused by gram-positive organisms resistant to most other antibiotics, including vancomycin-resistant enterococci and methicillin-resistant </span><em>Staphylococcus aureus</em>. As with any medication, adverse effects have been noted with linezolid, but they usually are mild to moderate in intensity. Most commonly seen are headache, nausea, vomiting, and diarrhea. Linezolid is a very expensive antibiotic and should be used only for treatment of serious infections caused by microorganisms that are resistant to other antibiotics. Linezolid is a Pregnancy Category C drug. Physicians should use the antibiotic with caution in pregnant and lactating women and only when the benefit clearly outweighs the potential risk to the fetus or infant.</p></div>","PeriodicalId":80301,"journal":{"name":"Primary care update for Ob/Gyns","volume":"9 5","pages":"Pages 178-180"},"PeriodicalIF":0.0000,"publicationDate":"2002-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1068-607X(02)00114-2","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Primary care update for Ob/Gyns","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1068607X02001142","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Linezolid (Zyvox) is a member of the first new category of antibiotics in 35 years. It is an oxazolidinone that blocks bacterial protein synthesis by a method unlike any other antibiotic, making cross-resistance unlikely. It is available in oral and intravenous formulations and can be used to treat infections caused by gram-positive organisms resistant to most other antibiotics, including vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus. As with any medication, adverse effects have been noted with linezolid, but they usually are mild to moderate in intensity. Most commonly seen are headache, nausea, vomiting, and diarrhea. Linezolid is a very expensive antibiotic and should be used only for treatment of serious infections caused by microorganisms that are resistant to other antibiotics. Linezolid is a Pregnancy Category C drug. Physicians should use the antibiotic with caution in pregnant and lactating women and only when the benefit clearly outweighs the potential risk to the fetus or infant.

利奈唑胺(Zyvox)
利奈唑胺(Zyvox)是35年来第一个新类别抗生素的成员。它是一种恶唑烷酮,通过一种不同于其他抗生素的方法阻止细菌蛋白质的合成,使交叉耐药性不太可能发生。它有口服和静脉注射剂型,可用于治疗对大多数其他抗生素(包括耐万古霉素肠球菌和耐甲氧西林金黄色葡萄球菌)具有耐药性的革兰氏阳性菌引起的感染。与任何药物一样,利奈唑胺的副作用也被注意到,但它们的强度通常是轻微到中度的。最常见的症状是头痛、恶心、呕吐和腹泻。利奈唑胺是一种非常昂贵的抗生素,只能用于治疗由对其他抗生素有耐药性的微生物引起的严重感染。利奈唑胺是妊娠C类药物。医生在孕妇和哺乳期妇女中应谨慎使用抗生素,并且只有在益处明显超过对胎儿或婴儿的潜在风险时才应使用抗生素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信